**Core Concept:**
The t(15;19) translocation is a specific chromosomal abnormality in which segments of chromosomes 15 and 19 are exchanged, leading to a change in the genetic makeup of affected cells. In medical genetics and hematology, translocations are significant because they can lead to the production of abnormal proteins or other changes that impact cell function and potentially cause diseases like leukemia or other cancers.

**Why the Correct Answer is Right:**
The correct answer, t(15;19), refers to a specific chromosomal rearrangement involving chromosomes 15 and 19. This translocation is associated with a rare form of acute myeloid leukemia (AML) called acute promyelocytic leukemia (APL). The t(15;19) translocation results in the fusion of PML (promyelocytic leukemia) and RARA (retinoic acid receptor alpha) genes, leading to the production of a chimeric protein that disrupts normal cellular functions and promotes leukemia development.

**Why Each Wrong Option is Incorrect:**
Option A (t(12;21)) represents a different type of chromosomal translocation associated with a different form of AML called core-binding factor leukemia (CBF-AML).
Option B (t(15;17)) is another translocation commonly found in APL, but it involves PML and RARA genes, unlike t(15;19).
Option C (t(15;21)) is incorrect as it refers to a different translocation not associated with AML.
Option D (t(15;22)) refers to a translocation not related to leukemia or any known clinical condition.

**Clinical Pearl:**
The t(15;19) translocation is a rare and relatively benign chromosomal abnormality, but it is essential for medical students and practicing physicians to understand the significance of different chromosomal translocations in leukemia, as this knowledge helps in diagnosis, prognosis, and treatment planning for affected patients. Recognizing specific translocations like t(15;19) is crucial for accurate diagnosis and targeted therapy in hematology and oncology.